Figure 6.
![Event-free survival plots for 5-year outlook on the full cohort. Patients were stratified by the classifier using CLL-IPI variables (TP53 aberrations, IGHV mutational status, B2M level, clinical stage, and age [IPI]) (A,C,E,G) and addition of (para)clinical variables to the CLL-IPI variables (+BL) (B,D,F,H). Overall survival (A-B), treatment-free survival (C-D), treatment and infection–free survival (E-F), and infection-free survival (G-H). HR, hazard ratio.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/6/12/10.1182_bloodadvances.2021006351/3/advancesadv2021006351f6.png?Expires=1724962969&Signature=2zqfh7E43mJv7eTHt8bcyBq-qVD1MruHUZSpY0AEgKUJimgOuNq2afYGKvMY6iHMatpGM92Hc46gljLGwdHA5L9eyMsM7p9d-hcslNXAzkOeGsaAc53FMxuiTozALhVczSvGiylsipOP5kAKAEDqCbQZe3IjgIggNg1jUkABA9C14fUuhrXFNsy0nlyLVfvrlFg5lbdSVbemsdjJ94Mi1awU1onTui3XjD5AQlYcfFl9aZvylFb9iUjiJbEPepIcw8nx~pO8oJTounw1CGANRTjK0cmTyTUvWhpigDqXBJL9d5xUQGmuZUm2UkkEFCjMdyV4V0ZD15Bb-dHgGYTpJQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Event-free survival plots for 5-year outlook on the full cohort. Patients were stratified by the classifier using CLL-IPI variables (TP53 aberrations, IGHV mutational status, B2M level, clinical stage, and age [IPI]) (A,C,E,G) and addition of (para)clinical variables to the CLL-IPI variables (+BL) (B,D,F,H). Overall survival (A-B), treatment-free survival (C-D), treatment and infection–free survival (E-F), and infection-free survival (G-H). HR, hazard ratio.